Coagulation Factor VIII Activity (Factor VIII)
Essential antihemophilic clotting factor glycoprotein that circulates stabilized in non-covalent complex with Von Willebrand Factor (VWF).
Standard vs. Optimal Reference Ranges% Activity
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
50 - 150%
General reference distribution across unselected commercial populations.
60 - 130%
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Activated by thrombin into Factor VIIIa, which serves as cofactor for Factor IXa in the intrinsic tenase complex on platelet surfaces.
Differential Diagnosis
Elevated Levels (Factor VIII High)
- •Acute phase reactant elevation (chronic inflammation, pregnancy)
- •High independent venous thrombosis risk (>150%)
Low Levels (Factor VIII Low)
- •Hemophilia A (Factor VIII deficiency, severe bleeding diathesis)
- •Von Willebrand disease (secondary clearance)
- •Factor VIII inhibitors (acquired hemophilia)
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for Factor VIII
- Targeted organ system imaging or functional dynamic testing related to intrinsic tenase complex
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Coagulation Factor VIII Activity - The New England Journal of Medicine (2021). PMID: 34090124
- [2]Factor VIII Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Coagulation Factor VIII Activity (Factor VIII) into overall healthspan optimization.